₹-3.89
(Market cap
₹133 Cr
Recently Viewed
Clear AllMarket cap
₹133 Cr
Revenue (TTM)
₹145 Cr
P/E Ratio
27.6
P/B Ratio
2.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹5 Cr
ROE
10.4 %
ROCE
13 %
Industry P/E
49.8
EV/EBITDA
10.1
Debt to Equity
1.1
Book Value
₹50
EPS
₹3.8
Face value
10
Shares outstanding
12,589,000
CFO
₹48.51 Cr
EBITDA
₹111.99 Cr
Net Profit
₹18.18 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lactose (India)
| 3.2 | 22.9 | 4.8 | -7.5 | 34.0 | 34.0 | 3.1 |
|
BSE Healthcare
| 0.1 | 2.8 | 5.2 | 3.6 | 24.0 | 13.2 | 10.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Lactose (India)
| -53.7 | 79.9 | 134.4 | 38.2 | 65.0 | 37.1 | -67.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lactose (India)
|
105.9 | 133.3 | 145.3 | 4.8 | 7.3 | 8 | 27.6 | 2.1 |
| 2,423.2 | 19,833.3 | 1,215.1 | 284.8 | 28.7 | 21.1 | 69.1 | 13.0 | |
| 764.6 | 15,021.4 | 7,266.8 | 627.5 | 11.9 | 12.6 | 23.9 | 2.8 | |
| 362.9 | 13,894.8 | 2,051.5 | 180.5 | 11.6 | 7.7 | 68.9 | 3.6 | |
| 672.8 | 16,680.5 | 5,092.5 | 545.5 | 15.9 | 14.1 | 30.6 | 3.8 | |
| 1,071.0 | 19,182.7 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.3 | 2.2 | |
| 1,611.0 | 18,467.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 918.7 | 3.2 | |
| 153.8 | 20,457.1 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.6 | |
| 436.0 | 17,562.1 | 3,720.2 | 352.1 | 13.7 | 8.2 | 49.9 | 3.7 | |
| 1,450.3 | 23,577.6 | 3,151.0 | -10.0 | 8.4 | 2.5 | 1071.7 | 5.1 |
No Review & Analysis are available.
Lactose (India) Limited manufactures and trades in pharmaceutical products in India. The company offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in liquid dose forms. It also provides... disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic; and galacto-oligosaccharides, a prebiotic for use in dairy and bakery products, beverages, infant and clinical nutrition, and geriatric nutrition applications, as well as in products for children or adolescents. The company also exports its products to Russia, Kazakhstan, Belarus, Nigeria, Sri Lanka, and other countries. Lactose (India) Limited was founded in 1991 and is headquartered in Mumbai, India. Read more
Incorporated
1991
Chairman
--
Managing Director
Atul Maheshwari
Group
Toshniwal
Headquarters
Vadodara Dist, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Lactose (India) Ltd is ₹105.87 (BSE) as of 22-Apr-2026 IST. Lactose (India) Ltd has given a return of 33.99% in the last 3 years.
The P/E ratio of Lactose (India) Ltd is 27.61 times as on 22-Apr-2026, a 45 discount to its peers’ median range of 49.80 times.
The P/B ratio of Lactose (India) Ltd is 2.12 times as on 22-Apr-2026, a 36 discount to its peers’ median range of 3.31 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
21.63
|
2.14
|
|
2024
|
25.87
|
3.73
|
|
2023
|
45.81
|
1.37
|
|
2022
|
30.79
|
1.92
|
|
2021
|
0.00
|
0.89
|
The 52-week high and low of Lactose (India) Ltd are Rs 136.70 and Rs 76.01 as of 23-Apr-2026.
Lactose (India) Ltd has a market capitalisation of ₹ 133 Cr as on 22-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Lactose (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.